AI-Powered Immunoisolation Membrane for Advanced Transplantation

The original patent disclosed a chamber for transplantation with a membrane for immunoisolation, but it had limitations in terms of scalability, adaptability, and integration with artificial components. The new invention addresses these limitations by introducing adaptive membranes, AI-powered monitoring, and hybrid organ-chamber designs, enabling more effective and personalized transplantation.

The new invention's adaptive membrane, AI-powered monitoring system, and hybrid organ-chamber design represent a significant departure from the original patent's static membrane and limited scalability. These features provide a more effective, personalized, and scalable solution for transplantation, making the original invention obsolete.

Alternative embodiments of the invention could include different materials and geometries for the adaptive membrane, various AI algorithms for the monitoring system, and diverse hybrid organ-chamber designs for specific applications. Additionally, the invention could be adapted for use in other fields, such as tissue engineering or biofabrication.

The invention has significant commercial potential in the fields of regenerative medicine, personalized transplantation, and large-scale biological constituent production. Target industries include pharmaceuticals, biotechnology, and medical devices, with potential applications in organ transplantation, tissue engineering, and biofabrication.